Neoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy
Clinical trial NCT05469022 · RECRUITING
Trial details
- NCT number
- NCT05469022
- Sponsor
- Konkuk University Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-19
- Primary completion
- 2024-05-19
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.